ABL1 |
P00519
|
ABL proto-oncogene 1, non-receptor tyrosine kinase
|
Kinase
|
1.00 |
0.432 |
0.923 |
ALL1 |
|
Leukemia, acute lymphocytic, susceptibility to, 1
|
|
|
0.636 |
0.269 |
BCL2 |
P10415
|
BCL2 apoptosis regulator
|
Signaling
|
0.56 |
0.291 |
0.885 |
BCR |
P11274
|
BCR activator of RhoGEF and GTPase
|
Enzyme modulator
|
0.99 |
0.431 |
0.885 |
BTK |
Q06187
|
Bruton tyrosine kinase
|
Kinase
|
1.00 |
0.464 |
0.808 |
CD19 |
P15391
|
CD19 molecule
|
|
0.90 |
0.430 |
0.885 |
CD22 |
P20273
|
CD22 molecule
|
|
0.80 |
0.556 |
0.615 |
CD33 |
P20138
|
CD33 molecule
|
Receptor
|
5.7E-07 |
0.524 |
0.769 |
CD6 |
P30203
|
CD6 molecule
|
Enzyme
|
9.3E-05 |
0.489 |
0.808 |
CDKN2A |
P42771 Q8N726
|
cyclin dependent kinase inhibitor 2A
|
|
0.39 |
0.300 |
0.885 |
CDKN2B |
P42772
|
cyclin dependent kinase inhibitor 2B
|
|
7.3E-03 |
0.417 |
0.769 |
CDR3 |
|
Cerebellar degeneration-related autoantigen-3
|
|
|
0.472 |
0.808 |
CRLF2 |
Q9HC73
|
cytokine receptor like factor 2
|
Signaling
|
3.3E-07 |
0.615 |
0.538 |
DNMT3A |
Q9Y6K1
|
DNA methyltransferase 3 alpha
|
|
7.4E-39 |
0.445 |
0.846 |
ETV5 |
P41161
|
ETS variant transcription factor 5
|
Transcription factor
|
1.00 |
0.565 |
0.731 |
ETV6 |
P41212
|
ETS variant transcription factor 6
|
Transcription factor
|
0.97 |
0.477 |
0.731 |
EVPL |
Q92817
|
envoplakin
|
Cellular structure
|
5.7E-25 |
0.599 |
0.423 |
FAT1 |
Q14517
|
FAT atypical cadherin 1
|
|
1.2E-12 |
0.508 |
0.808 |
FLT3 |
P36888
|
fms related receptor tyrosine kinase 3
|
Kinase
|
0.61 |
0.462 |
0.654 |
FUT4 |
P22083
|
fucosyltransferase 4
|
Enzyme
|
7.7E-06 |
0.505 |
0.731 |
HLF |
Q16534
|
HLF transcription factor, PAR bZIP family member
|
Nucleic acid binding
|
0.95 |
0.628 |
0.615 |
IKZF1 |
Q13422
|
IKAROS family zinc finger 1
|
Transcription factor
|
1.00 |
0.533 |
0.769 |
IL15 |
P40933
|
interleukin 15
|
|
0.71 |
0.422 |
0.846 |
KMT2A |
Q03164
|
lysine methyltransferase 2A
|
|
1.00 |
0.410 |
0.885 |
LEF1 |
Q9UJU2
|
lymphoid enhancer binding factor 1
|
|
1.00 |
0.486 |
0.769 |